These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15954424)

  • 21. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.
    Beasley DW; Li L; Suderman MT; Guirakhoo F; Trent DW; Monath TP; Shope RE; Barrett AD
    Vaccine; 2004 Sep; 22(27-28):3722-6. PubMed ID: 15315852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.
    Appaiahgari MB; Vrati S
    Expert Rev Vaccines; 2010 Dec; 9(12):1371-84. PubMed ID: 21105774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China.
    Liu X; Yu Y; Li M; Liang G; Wang H; Jia L; Dong G
    Vaccine; 2011 Mar; 29(11):2127-30. PubMed ID: 21237278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
    Yang SE; Pan MJ; Tseng HF; Liau MY
    Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Japanese Encephalitis Vaccine.
    Mileno MD
    R I Med J (2013); 2020 Aug; 103(6):49-50. PubMed ID: 32752568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Japanese encephalitis vaccine for travelers: exploring the limits of risk.
    Shlim DR; Solomon T
    Clin Infect Dis; 2002 Jul; 35(2):183-8. PubMed ID: 12087525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Needle-free jet injection of small doses of Japanese encephalitis DNA and inactivated vaccine mixture induces neutralizing antibodies in miniature pigs and protects against fetal death and mummification in pregnant sows.
    Imoto J; Ishikawa T; Yamanaka A; Konishi M; Murakami K; Shibahara T; Kubo M; Lim CK; Hamano M; Takasaki T; Kurane I; Udagawa H; Mukuta Y; Konishi E
    Vaccine; 2010 Oct; 28(46):7373-80. PubMed ID: 20851083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cloning and expression of domain III of the envelope gene of Japanese encephalitis virus: evaluation for early clinical diagnosis by IgM ELISA.
    Shukla J; Bhargava R; Dash PK; Parida M; Tripathi N; Rao PV
    J Virol Methods; 2009 Jun; 158(1-2):165-70. PubMed ID: 19428586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute flaccid paralysis as an unusual presenting symptom of Japanese encephalitis: a case report and review of the literature.
    Chung CC; Lee SS; Chen YS; Tsai HC; Wann SR; Kao CH; Liu YC
    Infection; 2007 Feb; 35(1):30-2. PubMed ID: 17297587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study.
    Schuller E; Klade CS; Wölfl G; Kaltenböck A; Dewasthaly S; Tauber E
    Vaccine; 2009 Mar; 27(15):2188-93. PubMed ID: 19200452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A chimeric live attenuated vaccine against Japanese encephalitis.
    Jones T
    Expert Rev Vaccines; 2004 Jun; 3(3):243-8. PubMed ID: 15176941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities.
    Yu Y
    Vaccine; 2010 May; 28(21):3635-41. PubMed ID: 20226891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles.
    Konishi E; Fujii A; Mason PW
    J Virol; 2001 Mar; 75(5):2204-12. PubMed ID: 11160724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Field evaluation of commercial immunoglobulin M antibody capture ELISA diagnostic tests for the detection of Japanese encephalitis virus infection among encephalitis patients in Nepal.
    Khalakdina A; Shrestha SK; Malla S; Hills S; Thaisomboonsuk B; Shrestha B; Gibbons RV; Jacobson J
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e79-84. PubMed ID: 20346721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute undifferentiated fever caused by infection with Japanese encephalitis virus.
    Watt G; Jongsakul K
    Am J Trop Med Hyg; 2003 Jun; 68(6):704-6. PubMed ID: 12887030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies in the development of Japanese encephalitis vaccine: expression of virus envelope glycoprotein V3 (E) gene in yeast.
    Fujita H; Sumiyoshi H; Mori C; Manabe S; Takagi M; Yoshida I; Morita K; Fuke I; Fukai K; Igarashi A
    Bull World Health Organ; 1987; 65(3):303-8. PubMed ID: 2822272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Japanese encephalitis vaccines.
    Wkly Epidemiol Rec; 2006 Aug; 81(34/35):331-40. PubMed ID: 16933380
    [No Abstract]   [Full Text] [Related]  

  • 38. Japanese encephalitis: development of new candidate vaccines.
    Bharati K; Vrati S
    Expert Rev Anti Infect Ther; 2006 Apr; 4(2):313-24. PubMed ID: 16597211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of viremia formation between guinea-pigs infected with wild and attenuated (SA14-14-2) Japanese encephalitis viruses].
    Liu XY; Yu YX; Xu HS; Liang GD; Wang HY; Jia LL; Dong GM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Oct; 24(5):343-5. PubMed ID: 21280319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potency testing of inactivated tissue culture vaccine against Japanese encephalitis using antigen capture ELISA.
    Joshi AM; Walimbe AM; Banerjee K
    Acta Virol; 1997 Jun; 41(3):157-9. PubMed ID: 9385404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.